Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

Description complète

Détails bibliographiques

Auteurs principaux:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2006-04-01
Collection:	AIDS Research and Therapy
Accès en ligne:	http://www.aidsrestherapy.com/content/3/1/11
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!